Search
Treating Severe Depression with On-Demand Brain Stimulation
UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.Sorting Cancers by “Immune Archetypes” Represents Potential New Approach to Developing Precision Immunotherapies
Using data from over 300 patient tumors, UCSF researchers have described 12 classes of “immune archetypes” to classify cancer tumors. Their findings, published today in CELL, reveal that cancers from different parts of the body are immunologically similar to one another. These classifications provide unique strategies for enhancing each patient’s choice of cancer immunotherapies.Gynecologic Cancer and Lynch Syndrome: Identifying Genetic Variants Leads to Precision Treatment
Given the increased risks associated with Lynch syndrome for gynecologic, colon and other cancers, physicians at the UCSF Gynecologic Oncology Center now approach testing, surveillance and treatment based on each patient’s individual genetic risk.UCSF-led Study Uncovers Unique Stem Cell Trajectory in Lungs Damaged by COVID-19 and Pulmonary Fibrosis
In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo abnormal differentiation. Drs. Kathiriya and Wang, supervised by Hal Chapman, MD, and Tien Peng, MD, respectively, utilized stem cell organoid models to uncover a novel stem cell pathway that is seen in severely injured lungs from COVID-19 and idiopathic pulmonary fibrosis patients.UCSF Case Study: Same-Day Discharge After Pheochromocytoma Removal
San Francisco endocrine surgeon Sanziana Roman, MD, performed a posterior retroperitoneoscopic adrenalectomy (PRA) to remove a pheochromocytoma. This approach enabled the patient to be discharged home within hours of surgery and avoid prolonged hospitalization, thereby minimizing COVID-19 risk.UCSF Study Finds 25% of Patients with HPV+ Oropharynx Cancer May Require Chemoradiotherapy After Robotic Surgery
In a nearly 10-year retrospective study involving 136 carefully selected patients with HPV-positive (HPV+) oropharynx cancer, UC San Francisco researchers found that one in four may meet possible indications for adjuvant chemoradiotherapy following transoral robotic surgery (TORS).How 3D-Printed, Patient-Specific Models Reduce Orthopaedic Surgery Time and Improve Patient Outcomes
In this interview, Alexis Dang, MD, talks about the benefits to patients and surgeons and the first time he used a 3D-printed, patient-specific model for surgical planning.Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.Endoscopic Removal of a Giant Pituitary Adenoma: A UCSF Case Study
A patient’s giant pituitary adenoma was successfully removed at UC San Francisco via endoscopic transsphenoidal surgery, a technique that offers exceptional visualization.A Referral Guide for Physicians - UCSF Heart and Vascular Center
The UCSF Heart and Vascular Center is home to a world-class team of cardiologists, heart surgeons, vascular surgeons, transplant surgeons and other specialists, all working collaboratively to provide the highest-quality care for patients.Virtual Inpatient Diabetes Management Tools Minimize COVID-19 Risk for Staff and Improve Patient Outcomes
Automated virtual tools for inpatient diabetes management in use at UC San Francisco have helped the medical staff deliver safe and effective patient care while reducing their exposure to SARS-CoV-2.Patients with Intractable Headaches Find Relief at the UCSF Inpatient Headache Unit
UCSF Inpatient Headache Unit treats patients with headache disorders through intravenous infusions of medications such as dihydroergotamine, chlorpromazine and valproate. Patients experiencing frequent and severe migraine, cluster, post-traumatic and other headaches have had their pain alleviated through this service, which is offered by the UCSF Headache Center.UCSF Earns AHA Award for Improving Quality of Care for STEMI Patients
UC San Francisco has earned the American Heart Association’s Mission: Lifeline® Silver Plus Receiving Achievement Award for implementing specific quality improvement measures in treating patients who suffer severe heart attacks.Liver Transplant Program and Referral Information
With more than 13,000 people in the United States with end-stage liver disease awaiting a liver transplant,UCSF has made liver transplantation services a high priority.International Hematologic Conference Features UCSF Health Experts
Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 63rd Annual Meeting and Exposition. This year’s meeting will be held in Atlanta, Georgia – and virtually – from December 11-14, 2021.Referral Guide for Physicians - Neurology and Neurological Surgery
Referral and specialty care clinic information provided by UC San Francisco’s departments of Neurology and Neurological Surgery.International Breast Cancer Conference Features UCSF Health Experts
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 7-10.Clinical Advance - Minimally Invasive Cardiac Surgery
UCSF Health is a major referral and destination center for minimally invasive cardiac surgery, featuring high volumes, extensive experience and quality outcomes.UCSF’s Julie Ann Sosa, MD, Named President-Elect of the American Thyroid Association
Julie Ann Sosa, MD, MA, FACS, endocrine surgeon and chair of the Department of Surgery at UC San Francisco, has been named president-elect of the American Thyroid Association (ATA). She was previously the ATA’s treasurer.Javid Moslehi, MD, Named Chief of the New UCSF Cardio-Oncology & Immunology Program
Javid Moslehi, MD, has been named section chief of the new Cardio-Oncology & Immunology Program at UC San Francisco, which brings together cardiologists, oncologists, immunologists and researchers to promote the cardiovascular health of patients during cancer treatment and survivorship.New Evidence on How Alcohol and Caffeine Affect Heart Rhythm Found in UCSF Studies
In separate studies, UC San Francisco researchers examined the effects of two widely consumed beverages – coffee and alcohol – on irregular heartbeat.Manipulating Gut Microbiomes to Treat inflammatory Bowel Disease
Researchers at the Benioff Center for Microbiome Medicine at UCSF are working to accelerate understanding of how microbes promote health and prevent disease and to leverage this information to develop novel, effective treatments in the shortest possible time.Living Kidney Donation
The UCSF Connie Frank Transplant Center continues to explore new options, such as advanced donation vouchers, to provide patients who have end-stage renal disease (ESRD) the opportunity for a living donor transplant.UCSF-Led Study Confirms Some Cancer Immunotherapies May Lead to Myocarditis and Other Potentially Serious Arrhythmias
Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis.